Soy and Lactulose drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Soy (soy) and Lactulose (lactulose). Common drug interactions include blister among females and amino acid level increased among males.

The phase IV clinical study analyzes what interactions people have when they take Soy and Lactulose. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.

What is Soy?

Soy has active ingredients of soy. eHealthMe is studying from 562 Soy users. Check the latest studies of Soy.

What is Lactulose?

Lactulose has active ingredients of lactulose. It is often used in constipation. eHealthMe is studying from 46,960 Lactulose users. Check the latest studies of Lactulose.

On Jul, 20, 2026

13 people who take Soy and Lactulose together, and have interactions are studied.

What are the common drug interactions of Soy and Lactulose, by gender? *:

female:

Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
Decreased appetite
Pain
Skin erosion (a discontinuity of the skin)
Wound infection
Platelet count decreased
White blood cell count decreased
Hepatic cirrhosis (chronic liver disease characterized by replacement of liver tissue by fibrosis, scar tissue)
Alanine aminotransferase increased

male:

Amino acid level increased
Focal nodular hyperplasia (tumour of the liver)
Erythema (redness of the skin)
Fatigue (feeling of tiredness)
General physical health deterioration (weak health status)
Infection
Nausea (feeling of having an urge to vomit)
Pyrexia (fever)
Tachypnoea (a condition of rapid breathing over 20 per minute)
Hepatic failure (liver failure)

What are the common drug interactions of Soy and Lactulose, by age (0-1 to 60+)? *:

0-1:

Amino acid level increased
Focal nodular hyperplasia (tumour of the liver)
Hepatic failure (liver failure)
Hepatocellular carcinoma (liver cancer)
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development)
Liver transplant

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
Aspartate aminotransferase increased
Blood bilirubin increased
C-reactive protein increased
Dyspnoea (difficult or laboured respiration)
Erythema (redness of the skin)
Fatigue (feeling of tiredness)
Fibrin d dimer increased
Gamma-glutamyltransferase increased

What are the existing conditions these people have? *

Seizures (abnormal excessive or synchronous neuronal activity in the brain): 5 people, 38.46%
Liver Disorder (liver diseases): 4 people, 30.77%
Tyrosinaemia (tyrosine metabolism resulting in liver and kidney disturbances and mental retardation): 2 people, 15.38%
Hepatitis C: 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Soy and Lactulose?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously